Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunizations With AFFITOPE AD02 Applied During AFFiRiS002 and AFF004A in Patients With Alzheimer's Disease

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01357629

Enrollment

Registered

2011-05-23

Start date

2011-07-31

Completion date

2013-11-30

Last updated

2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer´s Disease

Keywords

Vaccination follow-up

Brief summary

This study examines the long term Safety Follow-up of first patients vaccinated with AD02.

Detailed description

Patients who have received AD02 during AFF002 and AFF004A will be observed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* participation in AFF002 and AFF004A

Exclusion criteria

* no vaccination with AD02

Design outcomes

Primary

Measure	Time frame	Description
Safety	up to 2 years	collection and evaluation of AEs, SAEs

Countries

Austria

Outcome results